'Vaccinated But...': Delay In Covaxin Approval By WHO Hits Indian Travellers
NDTV
WHO said after a meeting on Tuesday that its independent experts had sought "additional clarifications" from Covaxin maker Bharat Biotech.
Stuck in a village for nine months and unable to return to his job in Saudi Arabia, Sugathan P.R. is hoping the World Health Organization will approve the COVID-19 shot Covaxin, paving the way for his trip back.
Like Mr Sugathan, millions of Indians have taken Covaxin and many have complained of travel struggles as the vaccine has not been recognised for international travel by several countries.
"I cannot continue to remain idle here any further," said 57-year-old Sugathan, who returned to Pandalam village in Kerala in January to be with his family after missing his father's funeral last year when the pandemic disrupted flights.
"I had the option of going to Saudi and taking (additional doses of) Covishield after a four-day institutional quarantine, but I was not sure of its implications on my health," said Mr Sugathan, referring to AstraZeneca's vaccine.
